Brian I Carr, Vito Guerra, Volkan Ince, Burak Isik, Sezai Yilmaz. Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level.Liver research. 2023, 7 (3): 256-262
Yssa Rodriguez, Jack Dunfield, Tyson Roderique, Hong-Min Ni. Liver-adipose tissue crosstalk in alcohol-associated liver disease: The role of mTOR.Liver research. 2022, 6 (4): 227-237
Wen-Xing Ding, Hua Wang, Yuxia Zhang. Recent insights into the pathogeneses and therapeutic targets of liver diseases: Summary of the 4th Chinese American Liver Society/Society of Chinese Bioscientists in America Hepatology Division Symposium in 2021.Liver research. 2022, 6 (1): 50-57
Camellia Dalai, John Azizian, Harry Trieu, Anand Rajan, Formosa Chen, Tien Dong, Simon Beaven, James H Tabibian. Machine learning models compared to existing criteria for noninvasive prediction of endoscopic retrograde cholangiopancreatography-confirmed choledocholithiasis.Liver research. 2021, 5 (4): 224-231
Satyanarayana R Pondugula, Julia M Salamat, Kodye L Abbott, Patrick C Flannery, Mohammed Majrashi, Mohammed Almaghrabi, Manoj Govindarajulu, Sindhu Ramesh, Maninder Sandey, Suneel K Onteru, Chen-Che J Huang, Yoshimi Iwaki, Kristina Gill, Natasha Narayanan, Edwin McElroy, Darshini Desai, Rishi Nadar, Timothy Moore, Muralikrishnan Dhanasekaran. A clinically relevant combination treatment with doxorubicin and cyclophosphamide does not induce hepatotoxicity in C57BL/6J mice.Liver research. 2021, 5 (4): 239-242
Hua Sun, Hong-Min Ni, Jennifer M McCracken, Jephte Y Akakpo, Sam Fulte, Tara McKeen, Hartmut Jaeschke, Hua Wang, Wen-Xing Ding. Liver-specific deletion of mechanistic target of rapamycin does not protect against acetaminophen-induced liver injury in mice.Liver research. 2021, 5 (2): 79-87